Peripheral T cell responses to immunotherapy treatment in metastatic melanoma by Woodcock, V

Variability in body temperature in healthy adults and in patients receiving chemotherapy: prospective observational cohort study by Frazer, JS, Barnes, GE, Woodcock, V, Flanagan, E, Littlewood, T, Stevens, RJ, Fleming, S, Ashdown, HF

Testicular cancer in men with undescended testis: Insights from the Thames Valley Testicular Cancer database by Bryant, R, Hobbs, C, Richardson, C, Fox, S, Joseph, J, Verrill, C, Woodcock, V, Sullivan, M, Protheroe, A

Interim pharmacokinetic (PK) and pharmacodynamic (PD) data from the first-in-human study of NUC-3373, a pyrimidine nucleotide analogue, in patients with advanced solid tumors by Ghazaly, E, Woodcock, V, Spilipoulou, P, Spiers, L, Moschandreas, J, Griffiths, L, Gnanaranjan, C, Harrison, D, Evans, T, Blagden, S

First-in-human phase I study of the bromodomain and extraterminal motif inhibitor BAY 1238097: emerging pharmacokinetic/pharmacodynamic relationship and early termination due to un... by Postel-Vinay, S, Herbschleb, K, Massard, C, Woodcock, V, Soria, J-C, Walter, AO, Ewerton, F, Poelman, M, Benson, N, Ocker, M, Wilkinson, G, Middleton, MR

A first-in-human phase I study to determine the maximum tolerated dose of the oral Src/ABL inhibitor AZD0424 by Woodcock, V, Clive, S, Wilson, R, Coyle, V, Stratford, M, Folkes, L, Eastell, R, Barton, C, Jones, P, Kazmi-Stokes, S, Turner, H, Halford, S, Harris, A, Middleton, M